Raised plasma homocysteine as a risk factor for retinal vascular occlusive disease

被引:93
作者
Cahill, M
Karabatzaki, M
Meleady, R
Refsum, H
Ueland, P
Shields, D
Mooney, D
Graham, I
机构
[1] Royal Victorian Eye & Ear Hosp, Res Fdn, Dublin 2, Ireland
[2] Adelaide Meath Hosp, Natl Childrens Hosp, Dept Cardiol, Dublin 24, Ireland
[3] Univ Bergen, Dept Pharmacol, N-5021 Bergen, Norway
[4] Royal Coll Surgeons Ireland, Dept Clin Pharmacol, Dublin 2, Ireland
关键词
D O I
10.1136/bjo.84.2.154
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background/aims-A moderately elevated plasma concentration of the sulphur amino acid homocysteine is an independent risk factor for atherosclerotic vascular disease. Many of the risk factors associated with coronary, cerebral, and peripheral atherosclerotic vascular disease are common to retinal vascular occlusive disease but it is unclear whether elevated plasma concentrations of homocysteine are also associated with such disease. This study assessed the relation between retinal vascular occlusive disease and elevated levels of plasma total homocysteine (tHcy). Methods-A retrospective case-control study involving hospital based controls and cases with retinal artery, central retinal vein (including hemiretinal vein), and branch retinal vein occlusions was performed. The relation between elevated tHcy, defined as a level greater than or equal to 12 mu mol/l and risk of retinal vascular occlusive disease was examined. Results-87 cases of retinal vascular occlusive disease including 26 cases of retinal artery occlusion, 40 cases with central retinal vein occlusion, and 21 cases of branch retinal vein occlusion were compared with 87 age matched controls. Mean tHcy levels were higher in all disease groups and this difference was significant in patients with retinal artery occlusions (p = 0.032) and patients with central retinal vein occlusion (p = 0.0001). When adjusted for known cardiovascular risk factors, tHcy was an independent risk factor for retinal vascular occlusive disease (OR 2.85 (95% CI 1.43-5.68)). Conclusions-Elevated tHcy is an independent risk factor for retinal vascular occlusive disease. Assessment of tHcy may be important in the investigation and management of patients with retinal vascular occlusive disease.
引用
收藏
页码:154 / 157
页数:4
相关论文
共 29 条
  • [21] VITAMIN STATUS AND INTAKE AS PRIMARY DETERMINANTS OF HOMOCYSTEINEMIA IN AN ELDERLY POPULATION
    SELHUB, J
    JACQUES, PF
    WILSON, PWF
    RUSH, D
    ROSENBERG, IH
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (22): : 2693 - 2698
  • [22] ABNORMAL-BLOOD VISCOSITY AND HEMOSTASIS IN LONG-STANDING RETINAL VEIN OCCLUSION
    TROPE, GE
    LOWE, GDO
    MCARDLE, BM
    DOUGLAS, JT
    FORBES, CD
    PRENTICE, CM
    FOULDS, WS
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 1983, 67 (03) : 137 - 142
  • [23] HOMOCYSTINURIA PRESENTING AS CENTRAL RETINAL ARTERY-OCCLUSION AND LONGSTANDING THROMBOEMBOLIC DISEASE
    VANDERBERG, W
    VERBRAAK, FD
    BOS, PJM
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 1990, 74 (11) : 696 - 697
  • [24] Homocysteine and atherothrombosis
    Welch, GN
    Loscalzo, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (15) : 1042 - 1050
  • [25] HYPERHOMOCYSTEINEMIA IN RETINAL ARTERY AND RETINAL VEIN OCCLUSION
    WENZLER, EM
    RADEMAKERS, AJJM
    BOERS, GHJ
    CRUYSBERG, JRM
    WEBERS, CAB
    DEUTMAN, AF
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 1993, 115 (02) : 162 - 167
  • [26] Central retinal vein occlusion: what's the story?
    Williamson, TH
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 1997, 81 (08) : 698 - 704
  • [27] INFLUENCE OF AGE, SYSTEMIC BLOOD-PRESSURE, SMOKING, AND BLOOD-VISCOSITY ON ORBITAL BLOOD VELOCITIES
    WILLIAMSON, TH
    LOWE, GDO
    BAXTER, GM
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 1995, 79 (01) : 17 - 22
  • [28] Blood viscosity, coagulation, and activated protein C resistance in central retinal vein occlusion: A population controlled study
    Williamson, TH
    Rumley, A
    Lowe, GDO
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 1996, 80 (03) : 203 - 208
  • [29] Yannuzzi LA, 1996, ARCH OPHTHALMOL-CHIC, V114, P545